Promoter yearly disclosure: no new pledges, holds 40.46% stake

Promoter Below 50pctOwnership Changes View source PDF

MEDICAMEQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.2%1-day move

₹227.80

prior close

₹231.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.3+0.4+1.7+3.4-0.2-0.3+5.5+9.0+15.1+14.2+3.2+3.6——

Up moveDown movePending

AI summary

Shivalik Rasayan Limited, the promoter of Medicamen Biotech, filed its yearly SEBI takeover disclosure. It holds 54,87,095 equity shares (40.46%) as of March 31, 2026, and confirmed no new encumbrance or pledge was created on shares during FY 2025-26.

Likely market impact

Promoter stake is below 50%, leaving the firm open to takeover bids. No fresh pledges ease near-term governance worry.